Cape Town | Representatives of The South African Medical Research Council (SAMRC) will join both private and government partners at the 2016 Bio International Convention opening today in San Francisco USA. The council joins a South African delegation of policy makers and pharma experts in encouraging global investment into South African bio technology research.
“South African science is globally relevant. We continue to invest in projects that not only grow the space of research and development but continue to highlight the need to invest in projects that will benefit under resourced communities,” says Executive Director: Grants, Innovation and Product Development at the SAMRC, Dr Richard Gordon.
The delegation intends to further entrench its commitment to enhancing the capacity of South African science by pursuing investors and investment opportunities whose contribution will advance health outcomes, benefit societies and improve on the overall existing South African health sciences landscape.
The SAMRC will showcase its biomedical investment projects through SHIP (Strategic Health and Innovation Partnerships); a health technology product development partnership that is a part of the Grants, Innovation and Product Development Unit (GIPD) headed by Gordon. This innovative unit is supported by the Department of Science and Technology of South Africa. SHIP has embarked on and funded a number of projects that are aimed at transferring research outputs to improve health outcomes for under resourced communities in South Africa. Some flagship projects that SHIP will be showcasing at the 2016 BIO International Convention include TB and malaria drug discovery projects; the clinical guideline app; the secure airway clamp as well as the mobile triage app.
“If we are investing in biomedical research innovation and interventions that can be translated to scale and ultimately benefit our people, then we are responding to the needs of South Africans, say Professor Glenda Gray, President & CEO of the SAMRC.
The BIO International Convention is the largest global event for the biotechnology industry and attracts leaders in biotechnology and life sciences. The convention offers key networking and partnering opportunities and also provides insights and inspiration on major trends affecting the industry.
Tel: +27 71 214 5272